Therapeutic antibodies are one of the most successful classes of biotherapeutics available, but the traditional antibody development process is cumbersome and has significant limitations. Using artificial intelligence (AI) to speed up theRead More…
Creative Biolabs at the 13th Annual World Bispecific Summit
With more clinical candidates and commercial success than ever within this rapidly developing space, multi-specifics is evidently the fourth wave of drug discovery. It’s a great honor for Creative Biolabs to participateRead More…